Biolife fX products "adulterated," FDA warns company.
This article was originally published in The Tan Sheet
Executive Summary
BIOLIFE "FX" PRODUCTS DRAW FDA WARNING LETTER Jan. 3 stating that "as a result of the significant number of reported injuries to consumers associated with Cherry fX Bombs, Lemon fX Drops and Orange fX Rush which are distributed by you, FDA has investigated these products." The letter is addressed to Daniel Bricker of Escondido, Calif.-based Biolife Bioproducts.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning